Publications by authors named "Heidi Brie"

Claim this Profile
G
Gender-stratified hierarchical modeling of patient and physician determinants of antihypertensive treatment outcomes: pooled analysis of seven prospective real-world studies with 17,044 patients.
Dina Hamarneh, Nimer Alkhatib, Kris Denhaerynck, Stefaan Vancayzeele, Heidi Brié

Curr Med Res Opin· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hierarchical modeling of blood pressure determinants and outcomes following valsartan treatment in hypertensive patients with known comorbidities: pooled analysis of six prospective real-world studies including 11,999 patients.
Nimer Alkhatib, Diana Sun, Kris Denhaerynck, Dina Hamarneh, Yoleen Van Camp

Curr Med Res Opin· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study).
Elisabeth Van Aken, Mérédis Favreau, Eva Ramboer, Kris Denhaerynck, Karen MacDonald

Clin Ophthalmol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUS Study.
Anita M Leys, Eva Ramboer, Mérédis Favreau, Kris Denhaerynck, Karen MacDonald

Clin Ophthalmol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Hypertensive Patients with and without Diabetes: Pooled Analysis of Six Observational Valsartan Studies with 15,282 Evaluable Patients.
Noha Ashy, Thanh-Nga Nguyen, Kris Denhaerynck, Mahdi Gharaibeh, Abdulaziz Alhossan

Int J Chronic Dis· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-year outcomes in neovascular age-related macular degeneration with ranibizumab.
Julie Jacob, Heidi Brié, Anita Leys, Laurent Levecq, Filip Mergaerts

Int J Ophthalmol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting blood pressure outcomes using single-item physician-administered measures: a retrospective pooled analysis of observational studies in Belgium.
Lorenzo Villa, Diana Sun, Kris Denhaerynck, Stefaan Vancayzeele, Heidi Brié

Br J Gen Pract· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world variability in ranibizumab treatment and associated clinical, quality of life, and safety outcomes over 24 months in patients with neovascular age-related macular degeneration: the HELIOS study.
Jean-Marie Rakic, Anita Leys, Heidi Brié, Kris Denhaerynck, Christy Pacheco

Clin Ophthalmol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients.
Ivo Abraham, Yoleen Van Camp, Lorenzo Villa, Kris Denhaerynck, Diana Sun

J Clin Hypertens (Greenwich)· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling of blood pressure outcomes in patients with and without established cardiovascular or renal disease following treatment with valsartan (the PREVIEW study).
Karen Macdonald, Heidi Brié, Stefaan Vancayzeele, Christopher Lee, John Bowles

Arch Cardiovasc Dis· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.
Ivo Abraham, Karen MacDonald, Christine Hermans, Ann Aerts, Christopher Lee

Vasc Health Risk Manag· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling of blood pressure and total cardiovascular risk outcomes after second-line valsartan therapy: the BSCORE study.
Robert Lins, Nicolas Coen, Ann Aerts, Karen Macdonald, Heidi Brié

Arch Cardiovasc Dis· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of amlodipine-valsartan single-pill combinations: hierarchical modeling of blood pressure and total cardiovascular disease risk outcomes (the EXCELLENT study).
Robert Lins, Ann Aerts, Nicolas Coen, Christine Hermans, Karen MacDonald

Ann Pharmacother· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hierarchical linear and logistic modeling of outcomes of antihypertensive treatment in elderly patients: findings from the PREVIEW study.
Ivo Abraham, Lynnette Demosthenes, Karen MacDonald, Christopher S Lee, Sally Reel

Arch Gerontol Geriatr· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Later, lazier, and unluckier": a heuristic profile of high vulnerability is an independent predictor of uncontrolled blood pressure (the PREVIEW study).
Ivo Abraham, Christopher Lee, Minkyoung Song, Stefaan Vancayzeele, Heidi Brié

Int J Gen Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).
Patricia Van der Niepen, Annemie Woestenburg, Heidi Brié, Stefaan Vancayzeele, Karen MacDonald

Ann Pharmacother· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis